Cephaibol D
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Bioactive by-products |
| Catalog number | BBF-00508 |
| CAS | |
| Molecular Weight | 1642.93 |
| Molecular Formula | C80H123N17O20 |
Online Inquiry
Description
It is produced by the strain of Acremonium tubakii DSM 12774. It has weak antibacterial activity.
Specification
| IUPAC Name | (2S)-2-[[(2S)-1-[2-[[2-[[(2S)-2-[[2-[[2-[[2-[[2-[[2-[[(2S)-2-acetamido-3-phenylpropanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]-4-hydroxypyrrolidine-2-carbonyl]amino]-N-[1-[(2S)-4-hydroxy-2-[[1-[(2S)-2-[(1-hydroxy-3-phenylpropan-2-yl)carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]pentanediamide |
| Canonical SMILES | CC(C)CC(C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)N1CC(CC1C(=O)NC(CCC(=O)N)C(=O)NC(C)(C)C(=O)N2CC(CC2C(=O)NC(C)(C)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)CO)O)O)NC(=O)CNC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(CC5=CC=CC=C5)NC(=O)C |
| InChI | InChI=1S/C80H123N17O20/c1-44(2)35-52(85-58(103)40-82-65(110)73(4,5)91-68(113)76(10,11)93-69(114)77(12,13)92-66(111)74(6,7)88-61(106)53(83-45(3)99)37-47-29-24-21-25-30-47)60(105)87-75(8,9)67(112)94-80(18,19)72(117)96-41-49(100)38-55(96)63(108)86-51(32-33-57(81)102)59(104)89-79(16,17)71(116)97-42-50(101)39-56(97)64(109)90-78(14,15)70(115)95-34-26-31-54(95)62(107)84-48(43-98)36-46-27-22-20-23-28-46/h20-25,27-30,44,48-56,98,100-101H,26,31-43H2,1-19H3,(H2,81,102)(H,82,110)(H,83,99)(H,84,107)(H,85,103)(H,86,108)(H,87,105)(H,88,106)(H,89,104)(H,90,109)(H,91,113)(H,92,111)(H,93,114)(H,94,112)/t48?,49?,50?,51-,52-,53-,54-,55-,56-/m0/s1 |
| InChI Key | RJJBAWKMFSQLEV-RWZHRGJOSA-N |
Reference Reading
1. The N-terminal nonapeptide of cephaibols A and C: a naturally occurring example of mismatched helical screw-sense control
Ugo Orcel, Matteo De Poli, Marta De Zotti, Jonathan Clayden Chemistry. 2013 Nov 25;19(48):16357-65. doi: 10.1002/chem.201302648. Epub 2013 Oct 9.
The N-terminal nonapeptide domain of the fungal nonribosomal peptide antibiotics cephaibol A and cephaibol C (AcPheAib4LeuIvaGly- Aib) is reported to adopt a right-handed helical conformation in the crystalline state. However, this conformation is at odds with the left-handed helicity observed in solution in related synthetic oligomers capped with Ac-L-PheAib4 fragments. We report the synthesis of four diastereoisomers of the cephaibol N-terminal nonapeptide, and show by NMR and CD spectroscopy that the peptide containing the chiral amino acids Phe and Leu in the naturally occurring relative configuration exists in solution as an interconverting mixture of helical screw-sense conformers. In contrast, the nonapeptide containing the unnatural relative configuration at Phe and Leu adopts a single, stable helical screw-sense, which is left handed when the N-terminal Phe residue is L and right-handed when the N-terminal Phe residue is D.
2. Automated solid-phase concatenation of Aib residues to form long, water-soluble, helical peptides
Francis Zieleniewski, Derek N Woolfson, Jonathan Clayden Chem Commun (Camb). 2020 Oct 14;56(80):12049-12052. doi: 10.1039/d0cc04698a. Epub 2020 Sep 9.
Iterative coupling of 2-aminoisobutyric acid (Aib) has been achieved rapidly and efficiently using automated solid-phase peptide synthesis, employing diisopropylcarbodiimide (DIC) in the presence of ethyl cyanohydroxyiminoacetate (Oxyma). This method has allowed the first total synthesis of the fungal antibiotic Cephaibol D, and enabled the synthesis of water-soluble oligomers of Aib containing up to an unprecedented sequence of 17 consecutive Aib residues. Conformational analysis of the Aib oligomers in aqueous solution shows a length dependence in their CD spectra, with oligomers of more than 14 Aib residues apparently adopting structured helical conformations.
3. Crystal structures of cephaibols
Gábor Bunkóczi, Matthias Schiell, László Vértesy, George M Sheldrick J Pept Sci. 2003 Nov-Dec;9(11-12):745-52. doi: 10.1002/psc.496.
The crystal structures of the peptaibol antibiotics cephaibol A, cephaibol B and cephaibol C have been determined at ca. 0.9 A resolution. All three adopt a helical conformation with a sharp bend (of about 55 degrees) at the central hydroxyproline. All isovalines were found to possess the D configuration, superposition of all four models (there are two independent molecules in the cephaibol B structure) shows that the N-terminal helix is rigid and the C-terminus is flexible. There are differences in the hydrogen bonding patterns for the three structures that crystallize in different space groups despite relatively similar unit cell dimensions, but only in the case of cephaibol C does the packing emulate the formation of a membrane channel believed to be important for their biological function.
Recommended Products
| BBF-01693 | Doxorubicin EP Impurity A (Daunorubicin) | Inquiry |
| BBF-00764 | Cerebroside C | Inquiry |
| BBF-01829 | Deoxynojirimycin | Inquiry |
| BBF-02642 | Lactonamycin | Inquiry |
| BBF-02614 | Nystatin | Inquiry |
| BBF-03754 | CASTANOSPERMINE | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
